Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02946788 · ClinicalTrials.gov registry record · Phase 2
Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel
A Phase 2 study, sponsored by BioPharmX.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT02946788 is a Phase 2 study that has completed, run by BioPharmX. The registered enrollment target is 20 participants.
The verdict
NCT02946788, a Phase 2 study, has completed, sponsored by BioPharmX.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a multi center open label study intended to provide photo documentation and time to response data for BPX-01 1 and 2% minocycline topical gel for the treatment of moderate to severe non-nodular inflammatory acne vulgarism.
Interventions
- DRUG Minocycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-03-13 |
| Est. Completion | 2018-06-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02946788
The ClinicalTrials.gov registry entry for NCT02946788 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioPharmX, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Minocycline is the first listed.
NCT02946788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02946788 about?
NCT02946788 is a clinical study titled "Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel". This is a multi center open label study intended to provide photo documentation and time to response data for BPX-01 1 and 2% minocycline topical gel for the treatment of moderate to severe non-nodular inflammatory acne vulgarism.
What is the current status of trial NCT02946788?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2017-03-13. Estimated completion is 2018-06-01.
What interventions are being tested in trial NCT02946788?
The interventions under investigation include: Minocycline (DRUG).
Who is sponsoring clinical trial NCT02946788?
This trial is sponsored by BioPharmX, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.